Survey of Clinical Practice for Irritable Bowel Syndrome in East Asian Countries

Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries. Subjects and Methods: Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS. Results: Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists. Conclusion: This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries.

[1]  M. Hongo,et al.  Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  W. Whitehead,et al.  Conducting multinational, cross‐cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team report , 2014, Alimentary pharmacology & therapeutics.

[3]  J. West,et al.  Review article: the economic impact of the irritable bowel syndrome , 2014, Alimentary pharmacology & therapeutics.

[4]  U. Ghoshal,et al.  A four‐country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[5]  D. Drossman,et al.  The narcotic bowel syndrome: a recent update. , 2014, American journal of gastroenterology supplements.

[6]  S. Fukudo,et al.  Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  Han Liu,et al.  A School-Based Study with Rome III Criteria on the Prevalence of Functional Gastrointestinal Disorders in Chinese College and University Students , 2013, PloS one.

[8]  A. Ford,et al.  Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  N. D. de Wit,et al.  Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. , 2011, The Cochrane database of systematic reviews.

[10]  S. Fukudo,et al.  Effect of 5‐HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[11]  T. Hausken,et al.  Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome , 2011, Alimentary pharmacology & therapeutics.

[12]  M. Hongo,et al.  Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo‐controlled and dose‐finding study , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[13]  K. Sugano,et al.  Diagnosis and treatment of functional gastrointestinal disorders in the Asia‐Pacific region: A survey of current practices , 2011, Journal of gastroenterology and hepatology.

[14]  Eun Soo Kim,et al.  Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: Focus on pain perception , 2010, Journal of gastroenterology and hepatology.

[15]  M. Hongo,et al.  Asian consensus on irritable bowel syndrome , 2010, Journal of gastroenterology and hepatology.

[16]  G. Michel,et al.  Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota , 2010, Nature.

[17]  Lin Chang,et al.  Differences in Gastrointestinal Symptoms According to Gender in Rome II Positive IBS and Dyspepsia in a Latin American Population , 2010, The American Journal of Gastroenterology.

[18]  A. Zinsmeister,et al.  Diarrhea-Predominant Irritable Bowel Syndrome Is Associated With Diverticular Disease: A Population-Based Study , 2010, The American Journal of Gastroenterology.

[19]  T. Okumura,et al.  Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan , 2010, Journal of Gastroenterology.

[20]  D. Drossman.  Beyond Tricyclics: New Ideas for Treating Patients With Painful and Refractory Functional Gastrointestinal Symptoms , 2009, The American Journal of Gastroenterology.

[21]  D. A. van der Windt,et al.  Systematic review: accuracy of symptom‐based criteria for diagnosis of irritable bowel syndrome in primary care , 2009, Alimentary pharmacology & therapeutics.

[22]  P. Moayyedi,et al.  Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. , 2009, Archives of internal medicine.

[23]  N. D. de Wit,et al.  Psychological treatments for the management of irritable bowel syndrome. , 2009, The Cochrane database of systematic reviews.

[24]  P. Moayyedi,et al.  The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review , 2008, Gut.

[25]  M. Hongo,et al.  High Prevalence of Irritable Bowel Syndrome in Medical Outpatients in Japan , 2008, Journal of clinical gastroenterology.

[26]  S. Fukudo,et al.  T1414 Effects of Mosapride Citrate, a 5-HT4 Receptor Agonist, On Rectosigmoid Motor and Sensory Function in Patients with Irritable Bowel Syndrome , 2008 .

[27]  M. Camilleri,et al.  Symptomatic overlap between irritable bowel syndrome and microscopic colitis. , 2011, Inflammatory bowel diseases.

[28]  M. Içer,et al.  Ultrasonographic evaluation of gallbladder functions in patients with irritable bowel syndrome , 2006, Journal of gastroenterology and hepatology.

[29]  L. Houghton,et al.  Systematic review: the efficacy of treatments for irritable bowel syndrome – a European perspective , 2006, Alimentary pharmacology & therapeutics.

[30]  G. Locke,et al.  GASTROENTEROLOGY 2006;130:1435–1446 Gender, Age, Society, Culture, and the Patient’s Perspective in the Functional Gastrointestinal Disorders , 2022 .

[31]  D. Drossman,et al.  The functional gastrointestinal disorders and the Rome III process. , 1999, Gastroenterology.

[32]  L. Chang,et al.  Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact , 2005, Alimentary pharmacology & therapeutics.

[33]  S. Dolwani,et al.  Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology , 2004, Alimentary pharmacology & therapeutics.

[34]  B. Spiegel,et al.  Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. , 2004, Gastroenterology.

[35]  A. Hoes,et al.  Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome , 2004, Alimentary pharmacology & therapeutics.

[36]  M. Crowell,et al.  Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea , 2003, American Journal of Gastroenterology.

[37]  W. Chey,et al.  The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review , 2002, American Journal of Gastroenterology.

[38]  A. Kilbourne,et al.  The impact of irritable bowel syndrome on health-related quality of life. , 2000, Gastroenterology.

[39]  J. Kellow,et al.  Functional gastrointestinal disorders: psychological, social, and somatic features , 1998, Gut.